Niche Therapeutics TheraLife specializes in botanical drugs and delivery technology for ocular conditions and pain management, suggesting sales opportunities with ophthalmology clinics, integrative medicine practitioners, and pain management specialists seeking non-pharmacologic or reduced side-effect options.

Clinical Validation Completed a Phase IIb multi-site double-blind trial for TheraLife Eye Enhanced with positive dry eye results, enabling credibility when approaching eye care providers and clinical researchers for partnerships, co-marketing, or expanded trials.

Regulatory & Quality FDA registered and GMP-compliant manufacturing in California reinforces trust with healthcare buyers and distributors requiring compliant, high-quality botanicals, opening doors with hospitals, clinics, and retail pharmacy channels.

Global Patents Three U.S. patents granted with more pending indicate defensible technology and potential licensing or collaboration opportunities with larger pharma or nutraceutical firms seeking botanical delivery platforms.

Growing Revenue Current revenue range ($10M–$25M) and small team size (2–10 employees) imply agility and potential for scalable partnerships, channel diversification, and white-label or contract manufacturing arrangements to accelerate growth.